Try our Advanced Search for more refined results

Drugmaker To Pay $4M To End Claims It Dodged FDA Fees

By Dave Simpson (February 22, 2019, 7:23 PM EST) -- A Pennsylvania drugmaker has agreed to pay $4 million to end False Claims Act allegations it tried to circumvent U.S. Food and Drug Administration fees by paying companies eligible for fee waivers to submit its new drug applications under their names, prosecutors announced Friday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!